Yao, R. J. R., Holmes, D. N., Andrade, J. G., Levin, A., Piccini, J. P., & Fordyce, C. B. (2023). Variability in Nonvitamin K Oral Anticoagulant Dose Eligibility and Adjustment According to Renal Formulae and Clinical Outcomes in Patients With Atrial Fibrillation With and Without Chronic Kidney Disease: Insights From ORBIT‐AF II. Journal of the American Heart Association, 12(6), e026605. https://doi.org/10.1161/JAHA.122.026605
Chicago Style (17th ed.) CitationYao, Ren Jie Robert, DaJuanicia N. Holmes, Jason G. Andrade, Adeera Levin, Jonathan P. Piccini, and Christopher B. Fordyce. "Variability in Nonvitamin K Oral Anticoagulant Dose Eligibility and Adjustment According to Renal Formulae and Clinical Outcomes in Patients With Atrial Fibrillation With and Without Chronic Kidney Disease: Insights From ORBIT‐AF II." Journal of the American Heart Association 12, no. 6 (2023): e026605. https://doi.org/10.1161/JAHA.122.026605.
MLA (9th ed.) CitationYao, Ren Jie Robert, et al. "Variability in Nonvitamin K Oral Anticoagulant Dose Eligibility and Adjustment According to Renal Formulae and Clinical Outcomes in Patients With Atrial Fibrillation With and Without Chronic Kidney Disease: Insights From ORBIT‐AF II." Journal of the American Heart Association, vol. 12, no. 6, 2023, p. e026605, https://doi.org/10.1161/JAHA.122.026605.